Literature DB >> 33027052

Mechanisms and early patterns of dyslipidemia in pediatric type 1 and type 2 diabetes.

Benjamin Udoka Nwosu1, Tony R Villalobos-Ortiz1, Gabrielle A Jasmin1, Sadichchha Parajuli1, Emily Zitek-Morrison2, Bruce A Barton2.   

Abstract

Objectives The is no consensus on the early patterns of lipid-based cardiovascular disease (CVD) risk in youth with either type 1 diabetes (T1D) or type 2 diabetes (T2D). The aim was todetermine the differences in CVD risk, using lipid profiles, in children and adolescents with either T1D or T2D at the time of their first lipid assessment, after stratifying the T1D cohort into remitters and non-remitters based on their honeymoon history. Methods A cross-sectional study of 249 subjects consisting of 73 controls, 53 T2D subjects, and 123 T1D subjects stratified into remitters (n=44), and non-remitters (n=79). Partial clinical remission (PCR) was defined as insulin-dose adjusted HbA1c of ≤9. Pubertal status was determined by Tanner staging. Results After adjusting for age, sex, BMI, race, and pubertal status, T2D patients had significantly higher LDL-C compared to the controls (p=0.022), the remitters (p=0.029), but not the non-remitters (103.1 ± 5.9 mg/dL vs. 91.4 ± 4.2 mg/dL, p=0.49). Similarly, T2D patients had significantly higher non-HDL-C compared to the controls (p=0.006), the remitters (p=0.0002), but not the non-remitters (137.6 ± 7.1 mg/dL vs. 111.71 ± 5.0 mg/dL, p=0.053). Total cholesterol was also significantly higher in T2D patients compared to the controls (p=0.0005), the remitters (p=0.006) but not the non-remitters (183.5 ± 6.6 mg/dL vs. 166.2 ± 4.8 mg/dL, p=0.27). Conclusions Lack of the honeymoon phase in children and adolescents with T1D confers early and significantly increased lipid-based cardiovascular risk to these patients that is similar to the elevated cardiovascular risk seen in T2D.

Entities:  

Keywords:  cardiovascular disease risk; children; dyslipidemia; honeymoon phase; type 1 diabetes; type 2 diabetes

Mesh:

Substances:

Year:  2020        PMID: 33027052      PMCID: PMC9064486          DOI: 10.1515/jpem-2020-0220

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.520


  61 in total

1.  Influence of HbA1c and BMI on Lipid Trajectories in Youths and Young Adults With Type 1 Diabetes.

Authors:  Michelle L Katz; Craig R Kollman; Carly E Dougher; Mohamed Mubasher; Lori M B Laffel
Journal:  Diabetes Care       Date:  2016-10-20       Impact factor: 19.112

2.  Association of insulin sensitivity to lipids across the lifespan in people with Type 1 diabetes.

Authors:  D M Maahs; K Nadeau; J K Snell-Bergeon; I Schauer; B Bergman; N A West; M Rewers; S R Daniels; L G Ogden; R F Hamman; D Dabelea
Journal:  Diabet Med       Date:  2011-02       Impact factor: 4.359

3.  The prevalence of dyslipidemia and associated factors in children and adolescents with type 1 diabetes.

Authors:  Tuba Bulut; Fatma Demirel; Ayşe Metin
Journal:  J Pediatr Endocrinol Metab       Date:  2017-02-01       Impact factor: 1.634

4.  2000 CDC Growth Charts for the United States: methods and development.

Authors:  Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Vital Health Stat 11       Date:  2002-05

5.  Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus.

Authors:  Mônica A L Gabbay; Maria N Sato; Claudia Finazzo; Alberto J S Duarte; Sergio A Dib
Journal:  Arch Pediatr Adolesc Med       Date:  2012-07-01

6.  Longitudinal screening of serum lipids in children and adolescents with Type 1 diabetes in a UK clinic population.

Authors:  J A Edge; T James; B Shine
Journal:  Diabet Med       Date:  2008-08       Impact factor: 4.359

7.  Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study.

Authors:  Diana B Petitti; Georgeanna J Klingensmith; Ronny A Bell; Jeanette S Andrews; Dana Dabelea; Giuseppina Imperatore; Santica Marcovina; Catherine Pihoker; Debra Standiford; Beth Waitzfelder; Elizabeth Mayer-Davis
Journal:  J Pediatr       Date:  2009-07-29       Impact factor: 4.406

8.  Dynamic changes of serum lipoproteins in children during adolescence and sexual maturation.

Authors:  G S Berenson; S R Srinivasan; J L Cresanta; T A Foster; L S Webber
Journal:  Am J Epidemiol       Date:  1981-02       Impact factor: 4.897

9.  Standards of Medical Care in Diabetes-2017 Abridged for Primary Care Providers.

Authors: 
Journal:  Clin Diabetes       Date:  2017-01

10.  Integration of Routine Parameters of Glycemic Variability in a Simple Screening Method for Partial Remission in Children with Type 1 Diabetes.

Authors:  Nina Nielens; Olivier Pollé; Annie Robert; Philippe A Lysy
Journal:  J Diabetes Res       Date:  2018-01-17       Impact factor: 4.011

View more
  2 in total

1.  Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes.

Authors:  Benjamin Udoka Nwosu; Sadichchha Parajuli; Krish Khatri; Gabrielle Jasmin; Layana Al-Halbouni; Austin F Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-17       Impact factor: 6.055

2.  The Theory of Hyperlipidemic Memory of Type 1 Diabetes.

Authors:  Benjamin Udoka Nwosu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.